Global Pyrazinamide Market

Pyrazinamide Comprehensive Study by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Adult, Pediatric)

Pyrazinamide Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026

Jan 2021 Edition 238 Pages 216 Tables & Figures

Summary
Market Segments
Table of Content
List of Tables & Figures
Companies Mentioned

Summary

Global Pyrazinamide Market Overview:

Pyrazinamide is used with other medications to treat tuberculosis (TB). It is an antibiotic and works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Pyrazinamide is indicated for the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents. Some of the players profiled in the study are Pure Chemistry Scientific (United States), LGM Pharma (United States), HBCChem (United States), Alfa Chemistry (United States), Toronto Research Chemicals (Canada), Acros Organics (United States), AlliChem (United States), Waterstone Technology (United States) and City Chemical (United States).

On the basis of geography, the market of Pyrazinamide has been segmented into . If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Pyrazinamide market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Adult will boost the Pyrazinamide market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers

Increasing Prevalence of Tuberculosis (TB) Disease
Growing Geriatric Population in Major Economies

Influencing Trend

Increasing Healthcare Spending and Demand for Drug Therapy

Restraints

Side Effects Due to Pyrazinamide Drug

Opportunities

R&D and Product Innovation
Potential Growth From Emerging Countries

Challenges

Stringent Government Rules and Regulation

The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail of competitive advantage through combined collaborations.

Target Audience:

Manufacturers of Pyrazinamide, Suppliers and Distributors of Pyrazinamide, Raw Material Suppliers, Commercial Research & Development (R&D) Institutions, Government Organizations, Research Organizations and Healthcare Industry

Major Objectives Focused through this Study

• To define, describe, and forecast the Global Pyrazinamide market on the basis of product [] , application [], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Pyrazinamide market with respect to major geographies, namely,
• To strategically profile the key players and analyzing their market shares and core competencies in the Pyrazinamide industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:

Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Pyrazinamide market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Market Segments

Report Objectives / Segmentation Covered

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By End User

Adult
Pediatric

By Regions

Table of Content

1. Market Overview
- 1.1. Introduction
- 1.2. Scope/Objective of the Study
  - 1.2.1. Research Objective
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
  - 3.2.1. Increasing Prevalence of Tuberculosis (TB) Disease
  - 3.2.2. Growing Geriatric Population in Major Economies
- 3.3. Market Challenges
  - 3.3.1. Stringent Government Rules and Regulation
- 3.4. Market Trends
  - 3.4.1. Increasing Healthcare Spending and Demand for Drug Therapy
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. Global Pyrazinamide, by Distribution Channel and End User (value and price ) (2015-2020)
- 5.1. Introduction
- 5.2. Global Pyrazinamide (Value)
  - 5.2.1. Global Pyrazinamide by: Distribution Channel (Value)
    - 5.2.1.1. Hospital Pharmacies
    - 5.2.1.2. Retail Pharmacies
    - 5.2.1.3. Online Pharmacies
  - 5.2.2. Global Pyrazinamide by: End User (Value)
    - 5.2.2.1. Adult
    - 5.2.2.2. Pediatric
- 5.3. Global Pyrazinamide (Price)
6. Pyrazinamide: Manufacturers/Players Analysis
- 6.1. Competitive Landscape
  - 6.1.1. Market Share Analysis
    - 6.1.1.1. Top 3
    - 6.1.1.2. Top 5
- 6.2. Peer Group Analysis (2020)
- 6.3. BCG Matrix
- 6.4. Company Profile
  - 6.4.1. Pure Chemistry Scientific (United States)
    - 6.4.1.1. Business Overview
    - 6.4.1.2. Products/Services Offerings
    - 6.4.1.3. Financial Analysis
    - 6.4.1.4. SWOT Analysis
  - 6.4.2. LGM Pharma (United States)
    - 6.4.2.1. Business Overview
    - 6.4.2.2. Products/Services Offerings
    - 6.4.2.3. Financial Analysis
    - 6.4.2.4. SWOT Analysis
  - 6.4.3. HBCChem (United States)
    - 6.4.3.1. Business Overview
    - 6.4.3.2. Products/Services Offerings
    - 6.4.3.3. Financial Analysis
    - 6.4.3.4. SWOT Analysis
  - 6.4.4. Alfa Chemistry (United States)
    - 6.4.4.1. Business Overview
    - 6.4.4.2. Products/Services Offerings
    - 6.4.4.3. Financial Analysis
    - 6.4.4.4. SWOT Analysis
  - 6.4.5. Toronto Research Chemicals (Canada)
    - 6.4.5.1. Business Overview
    - 6.4.5.2. Products/Services Offerings
    - 6.4.5.3. Financial Analysis
    - 6.4.5.4. SWOT Analysis
  - 6.4.6. Acros Organics (United States)
    - 6.4.6.1. Business Overview
    - 6.4.6.2. Products/Services Offerings
    - 6.4.6.3. Financial Analysis
    - 6.4.6.4. SWOT Analysis
  - 6.4.7. AlliChem (United States)
    - 6.4.7.1. Business Overview
    - 6.4.7.2. Products/Services Offerings
    - 6.4.7.3. Financial Analysis
    - 6.4.7.4. SWOT Analysis
  - 6.4.8. Waterstone Technology (United States)
    - 6.4.8.1. Business Overview
    - 6.4.8.2. Products/Services Offerings
    - 6.4.8.3. Financial Analysis
    - 6.4.8.4. SWOT Analysis
  - 6.4.9. City Chemical (United States)
    - 6.4.9.1. Business Overview
    - 6.4.9.2. Products/Services Offerings
    - 6.4.9.3. Financial Analysis
    - 6.4.9.4. SWOT Analysis
7. Global Pyrazinamide Sale, by Distribution Channel and End User (value and price ) (2021-2026)
- 7.1. Introduction
- 7.2. Global Pyrazinamide (Value)
  - 7.2.1. Global Pyrazinamide by: Distribution Channel (Value)
    - 7.2.1.1. Hospital Pharmacies
    - 7.2.1.2. Retail Pharmacies
    - 7.2.1.3. Online Pharmacies
  - 7.2.2. Global Pyrazinamide by: End User (Value)
    - 7.2.2.1. Adult
    - 7.2.2.2. Pediatric
- 7.3. Global Pyrazinamide (Price)
8. Appendix
- 8.1. Acronyms
9. Methodology and Data Source
- 9.1. Methodology/Research Approach
  - 9.1.1. Research Programs/Design
  - 9.1.2. Market Size Estimation
  - 9.1.3. Market Breakdown and Data Triangulation
- 9.2. Data Source
  - 9.2.1. Secondary Sources
  - 9.2.2. Primary Sources
- 9.3. Disclaimer

List of Tables & Figures

List of Tables

Table 1. Pyrazinamide: by Distribution Channel(USD Million)
Table 2. Pyrazinamide: by End User(USD Million)
Table 3. Company Basic Information, Sales Area and Its Competitors
Table 4. Company Basic Information, Sales Area and Its Competitors
Table 5. Company Basic Information, Sales Area and Its Competitors
Table 6. Company Basic Information, Sales Area and Its Competitors
Table 7. Company Basic Information, Sales Area and Its Competitors
Table 8. Company Basic Information, Sales Area and Its Competitors
Table 9. Company Basic Information, Sales Area and Its Competitors
Table 10. Company Basic Information, Sales Area and Its Competitors
Table 11. Company Basic Information, Sales Area and Its Competitors
Table 12. Pyrazinamide: by Distribution Channel(USD Million)
Table 13. Pyrazinamide: by End User(USD Million)
Table 14. Research Programs/Design for This Report
Table 15. Key Data Information from Secondary Sources
Table 16. Key Data Information from Primary Sources

List of Figures

Figure 1. Porters Five Forces
Figure 2. Supply/Value Chain
Figure 3. PESTEL analysis
Figure 4. Global Pyrazinamide: by Distribution Channel USD Million (2015-2020)
Figure 5. Global Pyrazinamide: by End User USD Million (2015-2020)
Figure 6. Global Pyrazinamide share by Players 2020 (%)
Figure 7. Global Pyrazinamide share by Players (Top 3) 2020(%)
Figure 8. Global Pyrazinamide share by Players (Top 5) 2020(%)
Figure 9. BCG Matrix for key Companies
Figure 10. Pure Chemistry Scientific (United States) Revenue, Net Income and Gross profit
Figure 11. Pure Chemistry Scientific (United States) Revenue: by Geography 2020
Figure 12. LGM Pharma (United States) Revenue, Net Income and Gross profit
Figure 13. LGM Pharma (United States) Revenue: by Geography 2020
Figure 14. HBCChem (United States) Revenue, Net Income and Gross profit
Figure 15. HBCChem (United States) Revenue: by Geography 2020
Figure 16. Alfa Chemistry (United States) Revenue, Net Income and Gross profit
Figure 17. Alfa Chemistry (United States) Revenue: by Geography 2020
Figure 18. Toronto Research Chemicals (Canada) Revenue, Net Income and Gross profit
Figure 19. Toronto Research Chemicals (Canada) Revenue: by Geography 2020
Figure 20. Acros Organics (United States) Revenue, Net Income and Gross profit
Figure 21. Acros Organics (United States) Revenue: by Geography 2020
Figure 22. AlliChem (United States) Revenue, Net Income and Gross profit
Figure 23. AlliChem (United States) Revenue: by Geography 2020
Figure 24. Waterstone Technology (United States) Revenue, Net Income and Gross profit
Figure 25. Waterstone Technology (United States) Revenue: by Geography 2020
Figure 26. City Chemical (United States) Revenue, Net Income and Gross profit
Figure 27. City Chemical (United States) Revenue: by Geography 2020
Figure 28. Global Pyrazinamide: by Distribution Channel USD Million (2021-2026)
Figure 29. Global Pyrazinamide: by End User USD Million (2021-2026)